Medicinal Cannabis and CBD in Mental Healthcare, 1st ed. 2021
This book functions as a clinician?s guide to the use of cannabidiol (CBD) in the treatment of mental health conditions. It conveys the scientific evidence of efficacy of CBD as well as THC and addresses the social stigma attached to its medical use.
The book describes the endocannabinoid system, how stress and the endocannabinoid system interact and key constituents, pharmacokinetics and safety aspects of medicinal cannabis, focusing on CBD and THC. Chapters on specific mental health conditions describe the underpinning pathomechanisms including how the endocannabinoid system is involved, and summarises the scientific evidence including animal and human research for the use of CBD and THC in treatment of such conditions. Topics covered include anxiety, depression, post-traumatic stress disorder, insomnia, Alzheimer's Disease and autism spectrum disorder. Chapters also discuss treatment guidelines and case studies.
Unique and focused, Medicinal Cannabis and CBD in Mental Healthcare is an invaluable reference for medical practitioners seeking to adopt CBD-use in their treatment plans.
Kylie O’Brien PhD
Adjunct Professor Torrens University
Director of Research & Education
Dr. Philip Blair, MD, Colonel (US Army Ret)
CEO of AbleDoc, Inc, International Medical Consultant
Chief Medical Officer, International College of Cannabinoid Medicine
Chief Medical Officer, Releaf Clinics, Australia
Chief Science Officer for Harvest 360
Date de parution : 10-2021
Ouvrage de 576 p.
15.5x23.5 cm
